Roger P. Dickinson
Pfizer (United Kingdom)(GB)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Inflammatory mediators and NSAID effects, Blood Coagulation and Thrombosis Mechanisms, Eicosanoids and Hypertension Pharmacology, Chemical Synthesis and Analysis
Most-Cited Works
- → UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity(1981)116 cited
- → A Potent, Selective Inhibitor of Matrix Metalloproteinase-3 for the Topical Treatment of Chronic Dermal Ulcers(2003)85 cited
- → Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus(1996)85 cited
- → Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines(2007)57 cited
- → The design and synthesis of a novel series of indole derived selective ETA antagonists(2002)39 cited
- → Electrophysiologic Properties of UK-66,914, a Novel Class III Antiarrhythmic Agent(1991)38 cited
- → Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2. Imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamides(1980)38 cited
- → Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles(1985)38 cited
- → Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines(2004)36 cited
- → Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines(2002)30 cited